Pfizer Ltd Reports 65.7% Net Profit Increase to Rs 313 Crore in September Quarter
Pfizer Ltd reported a 65.7% rise in net profit to Rs 313.25 crore for the September quarter, driven by exceptional gains of Rs 132.06 crore from the sale of Minipress XL by its parent company. The company’s profit before tax and exceptional items increased 13.9% to Rs 290.77 crore, while total income rose to Rs 774.19 crore. Pfizer discontinued manufacturing Minipress XL from September 7, 2026. Shares closed 3.37% higher at Rs 3,760.5 on the BSE.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (66/100). Lens Score 39/100.
Outlets measured: businessstandard, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (65–68/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 3 Nov, 10:17 am. Other outlets followed.
- 1
